查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475162

全球體內 CRO 市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global In Vivo CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

全球體內 CRO 市場需求預計將從 2023 年的 50.6 億美元達到近 101.9 億美元的市場規模，2024 年至 2032 年研究期間複合年成長率為 8.09%。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球 in vivo cro 市場的各個細分市場進行了包容性評估。體內微生物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

in vivo cro 市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按動物模型分類

  • 基於囓齒動物（大鼠模型、小鼠模型、其他囓齒動物模型）
  • 不囓齒類動物

按服務

  • 生物分析和 Dmpk 研究
  • 毒性研究（Glp 毒理學研究、非 Glp 毒理學研究）
  • 其他服務

依藥物類型

  • 小分子藥物
  • 大分子藥物（細胞和基因治療、RNA治療、其他）

按治療領域

  • 腫瘤學
  • 臨床藥理學
  • 心臟病學
  • 傳染性疾病
  • 神經病學
  • 胃腸病學和肝病學
  • 代謝與內分泌
  • 眼科
  • 自體免疫性/發炎性疾病
  • 其他

按最終用途

  • 製藥及生物製藥公司
  • 醫療器材公司
  • 學術及研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲體內 CRO 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。體內 CRO 市場的主要參與者包括 Biocytogen、Charles River Laboratories International Inc.、Crown Bioscience、Evotec、GemPharmatech、IQVIA Inc.、Icon Plc、Labcorp Drug Development、Parexel International Corporation、PsychoGenics Inc.、Taconic Biosciences, Inc.。節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：體內 CRO - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 動物模型的市場吸引力分析
    • 按服務分類的市場吸引力分析
    • 按藥物類型分類的市場吸引力分析
    • 按治療領域分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球體內 CRO 市場分析：按動物模型

  • 按動物模型概述
  • 歷史和預測數據
  • 動物模型分析
  • 基於囓齒動物（大鼠模型、小鼠模型、其他囓齒動物模型）
  • 不囓齒類動物

第 6 章：全球體內 CRO 市場分析：依服務分類

  • 按服務概覽
  • 歷史和預測數據
  • 按服務分析
  • 生物分析和 DMPK 研究
  • 毒性研究（GLP 毒理學研究、非 GLP 毒理學研究）
  • 其他服務

第 7 章：全球體內 CRO 市場分析：依藥物類型

  • 按藥物類型概述
  • 歷史和預測數據
  • 依藥物類型分析
  • 小分子藥物
  • 大分子藥物（細胞和基因治療、RNA治療、其他）

第 8 章：全球體內 CRO 市場分析：依治療領域

  • 按治療領域概述
  • 歷史和預測數據
  • 按治療領域分析
  • 腫瘤學
  • 臨床藥理學
  • 心臟病學
  • 傳染性疾病
  • 神經病學
  • 胃腸病學和肝病學
  • 代謝與內分泌
  • 眼科
  • 自體免疫性/發炎性疾病
  • 其他

第 9 章：全球體內 CRO 市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 製藥及生物製藥公司
  • 醫療器材公司
  • 學術及研究機構

第 10 章：全球體內 CRO 市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章：體內 CRO 公司的競爭格局

  • 體內CRO市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Biocytogen
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Charles River Laboratories International Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Crown Bioscience
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Evotec
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GemPharmatech
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IQVIA Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Icon Plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Labcorp Drug Development
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Parexel International Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • PsychoGenics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Taconic Biosciences Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114389

The global demand for In Vivo CRO Market is presumed to reach the market size of nearly USD 10.19 Billion by 2032 from USD 5.06 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vivo cro. The growth and trends of in vivo cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vivo cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Model

  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models)
  • Non-Rodent-Based

By Service

  • Bioanalysis & Dmpk Studies
  • Toxicity Studies (Glp Toxicology Studies, Non-Glp Toxicology Studies)
  • Other Services

By Drug Type

  • Small-Molecule Drugs
  • Large-Molecule Drugs (Cell & Gene Therapy, Rna Therapy, Other)

By Therapeutic Area

  • Oncology
  • Clinical Pharmacology
  • Cardiology
  • Infectious Diseases
  • Neurology
  • Gastroenterology & Hepatology
  • Metabolic & Endocrine
  • Ophthalmology
  • Autoimmune / Inflammatory Conditions
  • Other

By End-Use

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vivo CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vivo CRO market include Biocytogen, Charles River Laboratories International Inc., Crown Bioscience, Evotec, GemPharmatech, IQVIA Inc., Icon Plc, Labcorp Drug Development, Parexel International Corporation, PsychoGenics Inc., Taconic Biosciences, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN VIVO CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Animal Model
    • 3.7.2 Market Attractiveness Analysis By Service
    • 3.7.3 Market Attractiveness Analysis By Drug Type
    • 3.7.4 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VIVO CRO MARKET ANALYSIS BY ANIMAL MODEL

  • 5.1. Overview By Animal Model
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Animal Model
  • 5.4. Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Historic and Forecast Sales By Regions
  • 5.5. Non-Rodent-Based Historic and Forecast Sales By Regions

6. GLOBAL IN VIVO CRO MARKET ANALYSIS BY SERVICE

  • 6.1. Overview By Service
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Service
  • 6.4. Bioanalysis & DMPK Studies Historic and Forecast Sales By Regions
  • 6.5. Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Historic and Forecast Sales By Regions
  • 6.6. Other Services Historic and Forecast Sales By Regions

7. GLOBAL IN VIVO CRO MARKET ANALYSIS BY DRUG TYPE

  • 7.1. Overview By Drug Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Drug Type
  • 7.4. Small-Molecule Drugs Historic and Forecast Sales By Regions
  • 7.5. Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Historic and Forecast Sales By Regions

8. GLOBAL IN VIVO CRO MARKET ANALYSIS BY THERAPEUTIC AREA

  • 8.1. Overview By Therapeutic Area
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Therapeutic Area
  • 8.4. Oncology Historic and Forecast Sales By Regions
  • 8.5. Clinical Pharmacology Historic and Forecast Sales By Regions
  • 8.6. Cardiology Historic and Forecast Sales By Regions
  • 8.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 8.8. Neurology Historic and Forecast Sales By Regions
  • 8.9. Gastroenterology & Hepatology Historic and Forecast Sales By Regions
  • 8.10. Metabolic & Endocrine Historic and Forecast Sales By Regions
  • 8.11. Ophthalmology Historic and Forecast Sales By Regions
  • 8.12. Autoimmune / Inflammatory Conditions Historic and Forecast Sales By Regions
  • 8.13. Other Historic and Forecast Sales By Regions

9. GLOBAL IN VIVO CRO MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By End-use
  • 9.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 9.5. Medical Device Companies Historic and Forecast Sales By Regions
  • 9.6. Academic & Research Institutes Historic and Forecast Sales By Regions

10. GLOBAL IN VIVO CRO MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE IN VIVO CRO COMPANIES

  • 11.1. In Vivo CRO Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF IN VIVO CRO INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Biocytogen
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Charles River Laboratories International Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Crown Bioscience
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Evotec
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. GemPharmatech
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. IQVIA Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Icon Plc
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Labcorp Drug Development
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Parexel International Corporation
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. PsychoGenics Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Taconic Biosciences Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Animal Model (USD MN)
  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Market Sales By Geography (USD MN)
  • Non-Rodent-Based Market Sales By Geography (USD MN)
  • Analysis By Service (USD MN)
  • Bioanalysis & DMPK Studies Market Sales By Geography (USD MN)
  • Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Analysis By Drug Type (USD MN)
  • Small-Molecule Drugs Market Sales By Geography (USD MN)
  • Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Clinical Pharmacology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Gastroenterology & Hepatology Market Sales By Geography (USD MN)
  • Metabolic & Endocrine Market Sales By Geography (USD MN)
  • Ophthalmology Market Sales By Geography (USD MN)
  • Autoimmune / Inflammatory Conditions Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global In Vivo CRO Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vivo CRO Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vivo CRO Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Animal Model
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Animal Model (USD MN)
  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Market Sales By Geography (USD MN)
  • Non-Rodent-Based Market Sales By Geography (USD MN)
  • Global Market Analysis By Service (USD MN)
  • Bioanalysis & DMPK Studies Market Sales By Geography (USD MN)
  • Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Type (USD MN)
  • Small-Molecule Drugs Market Sales By Geography (USD MN)
  • Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Clinical Pharmacology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Gastroenterology & Hepatology Market Sales By Geography (USD MN)
  • Metabolic & Endocrine Market Sales By Geography (USD MN)
  • Ophthalmology Market Sales By Geography (USD MN)
  • Autoimmune / Inflammatory Conditions Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.